As of 2025-05-15, the Intrinsic Value of Novartis India Ltd (NOVARTIND.NS) is 344.32 INR. This NOVARTIND.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 674.00 INR, the upside of Novartis India Ltd is -48.90%.
The range of the Intrinsic Value is 317.18 - 390.26 INR
Based on its market price of 674.00 INR and our intrinsic valuation, Novartis India Ltd (NOVARTIND.NS) is overvalued by 48.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 317.18 - 390.26 | 344.32 | -48.9% |
| DCF (Growth 10y) | 342.10 - 418.94 | 370.94 | -45.0% |
| DCF (EBITDA 5y) | 449.46 - 566.04 | 473.31 | -29.8% |
| DCF (EBITDA 10y) | 430.03 - 543.36 | 458.37 | -32.0% |
| Fair Value | 775.32 - 775.32 | 775.32 | 15.03% |
| P/E | 501.58 - 684.14 | 603.02 | -10.5% |
| EV/EBITDA | 441.42 - 809.00 | 575.65 | -14.6% |
| EPV | 300.48 - 321.16 | 310.82 | -53.9% |
| DDM - Stable | 212.96 - 464.82 | 338.89 | -49.7% |
| DDM - Multi | 314.86 - 463.95 | 370.58 | -45.0% |
| Market Cap (mil) | 16,641.06 |
| Beta | 0.88 |
| Outstanding shares (mil) | 24.69 |
| Enterprise Value (mil) | 11,822.96 |
| Market risk premium | 8.83% |
| Cost of Equity | 12.10% |
| Cost of Debt | 7.95% |
| WACC | 12.01% |